Home / News / India News / Article / Serum Institute gets DCGI nod for clinical trials of Oxford vax

Serum Institute gets DCGI nod for clinical trials of Oxford vax

The SII received approval by the Indias top drug regulator on Sunday after a thorough evaluation based on the recommendations of the Subject Expert Committee on COVID-19

Listen to this article :
This image has been used for representational purposes only

This image has been used for representational purposes only

The Drugs Controller General of India (DCGI) has given approval to Pune's Serum Institute of India (SII) to conduct clinical trials of Oxford University-Astra Zeneca COVID-19 vaccine in India.

The SII received approval by the India's top drug regulator on Sunday after a thorough evaluation based on the recommendations of the Subject Expert Committee on COVID-19.

How do you like the new new mid-day.com experience? Share your feedback and help us improve.

Read Next Story
With Lord Hanuman's blessings, 'bhumi pujan' will end 166-year-old dispute

Trending Stories

Latest Photoscta-pos

Latest VideosView All

Latest Web StoriesView All

Mid-Day FastView All

Advertisement